Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Board Appointments

18 Jun 2021 07:00

RNS Number : 3116C
CentralNic Group PLC
18 June 2021
 

18 June 2021

 

 

CentralNic Group plc

("CentralNic" or the "Company", or the "Group")

 

Board Appointments

 

CentralNic Group plc (AIM: CNIC), the global internet platform that derives revenue from the subscription sales of domain names and web services, announces the appointment to its board of Matthew Max Edward Royde ("Max Royde") and Horst Oskar Siffrin as Non-executive Directors with immediate effect. Max and Horst are joining the board as shareholder representatives of Kestrel Partners LLP and inter.services GmbH respectively.

 

Max Royde is currently managing partner at Kestrel Partners, an investment management company specialising in business-critical software companies, which has a beneficial holding in CentralNic of 56,583,670 shares or 22.53%. Max co-founded Kestrel Partners in 2009 and is a fund manager of Kestrel Opportunities. Prior to Kestrel Max was a managing director of KBC Peel Hunt, running its technology franchise. He has over 20 years' experience focusing on the technology sector.

Horst Siffrin started his career as a German diplomat serving in Germany, the UK, Ethiopia, Nigeria, Bolivia, Poland and Spain. He is partner of inter.services holding/investments, which has a beneficial holding in the Company of 37,085,870 shares or 14.77% and owner of H.O. Siffrin Consulting based in Berlin. From August 2011 until the reverse takeover of CentralNic in August 2018 he was Chairman of the Supervisory Board of KeyDrive SA, Luxemburg and member of the Advisory Board of the Key-Systems Group. In 2018 he co-founded AstraPharma.

Ben Crawford, CEO of CentralNic commented: "We are delighted to welcome Max to our board. Through Kestrel Partners he has been a long-term investor and supporter of CentralNic. He has extensive experience of UK listed technology companies and capital markets and his knowledge will be invaluable to us as we continue to grow the Company.

We also welcome Horst onto our board. Having held senior positions at our 2018 acquisition KeyDrive, Horst understands both our industry and our business and we look forward to his support in taking CentralNic to the next stage in its growth." 

The following disclosures are made in relation to paragraph (g) of Schedule Two of the AIM Rules for Companies:

 

Matthew Max Edward Royde (age 49)

 

Current Directorships

Past Directorships within the last 5 years

Kestrel Partners LLP

Kestrel Investment Partners LLP

Elms Road Capital Limited

Ingenta plc

Charles Connell & Company Holdings Limited

IDE Group Holdings plc

Track Record Holdings Limited

Gresham Technologies Plc

Trailight Ltd

 

Findlay Park Partners LLP

 

IQGeo Group plc

 

 

 

Max Royde was appointed as a director of Hotel Buyer Limited on 10 October 2000 and resigned on 10 May 2005. On 31 May 2005, the company passed an extraordinary resolution to put the company into creditors voluntary liquidation. The company was dissolved on 26 January 2008.

 

Horst Oskar Siffrin (age 73)

 

Current Directorships

Past Directorships within the last 5 years

inter.services GmbH

KeyDrive SA

H.O. Siffrin Consulting

 

AstraPharma GmbH

 

IIG - Invest in Growth GmbH

 

PerspektiveAfrika E.V

 

Seniorenhilfe.Saarland E.V

 

phi GmbH

 

Gastehaus Residenz Aurora - Horst Siffrin e.K

 

 

 

 

 

-Ends-

For further information:

CentralNic Group Plc

Ben Crawford, Chief Executive Officer

Don Baladasan, Group Managing Director

Michael Riedl, Chief Financial Officer

 

 +44 (0) 203 388 0600

Zeus Capital Limited (NOMAD and Joint Broker)

Nick Cowles / Jamie Peel (Corporate Finance)

John Goold / Rupert Woolfenden 

(Institutional Sales)

 

 

+44 (0) 161 831 1512

+44 (0) 203 829 5000

Stifel (Joint Broker)

Fred Walsh / Alex Price / Richard Short

+44 (0) 20 7710 7600

 

 

SEC Newgate (for Media)

Bob Huxford / Tom Carnegie / Isabelle Smurfit

+44 (0) 203 757 6880

centralnic@secnewgate.co.uk

 

 

About CentralNic Group plc 

CentralNic (AIM: CNIC) is a London-based AIM-listed company which drives the growth of the global digital economy by developing and managing software platforms allows businesses globally to buy subscriptions to domain names for websites and email, monetise domain names, and protect their brands online. Its core growth strategy is identifying and acquiring cash-generative businesses in its industry with annuity revenue streams and exposure to growth markets and migrating them onto the CentralNic software and operating platforms. 

CentralNic operates globally with customers in almost every country in the world. It earns recurring revenues from the worldwide sales of internet domain names and other services on an annual subscription basis. 

For more information please visit: www.centralnicgroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUQPQUPGGMM
Date   Source Headline
15th Dec 202211:23 amRNSDirectors' Dealings
12th Dec 20227:00 amRNSLEADERSHIP CHANGE, UPDATE, SHARE BUYBACK INTENTION
30th Nov 20229:58 amRNSDirectors’ Dealings
28th Nov 20227:00 amRNSDirectors’ Dealings
28th Nov 20227:00 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSNINE MONTHS ENDED 30 SEP 2022 FINANCIAL RESULTS
9th Nov 20227:00 amRNSNotice of Results
31st Oct 202211:00 amRNSSuccessful Completion of Refinancing
26th Oct 20227:00 amRNSAcquisition Announcement
24th Oct 20221:32 pmRNSDirectors' Dealings
17th Oct 20227:00 amRNSQ3 Traing Upate, Refinancing Notice of Results
17th Oct 20227:00 amRNSQ3 Trading Update, Refinancing & Notice of Results
12th Oct 20221:59 pmRNSDirectors’ Dealings
12th Oct 202210:36 amRNSHolding(s) in Company - Replacement
11th Oct 20224:01 pmRNSHolding(s) in Company
11th Oct 20223:59 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirectors' Dealings
5th Oct 20227:00 amRNSDirectors’ Dealings
29th Sep 20227:00 amRNSDirectors’ Dealings
26th Sep 20227:00 amRNSDirectors' Dealings
14th Sep 20227:01 amRNSBoard Changes
14th Sep 20227:00 amRNSAcquisition Announcement
6th Sep 20225:38 pmRNSDirectors' Dealings
30th Aug 20227:00 amRNSSIX MONTHS ENDED 30 JUNE 2022 FINANCIAL RESULTS
29th Jul 20225:07 pmRNSDirectors' Dealings
25th Jul 20227:00 amRNSExercise of Options
18th Jul 20227:02 amRNSKeyDrive SA Final Add. Consideration Determined
18th Jul 20227:01 amRNSDirectors' Dealings
18th Jul 20227:00 amRNSH1 2022 Trading Update and Notice of Results
23rd May 20227:00 amRNSTHREE MONTHS ENDED 31 MARCH 2022 FINANCIAL RESULTS
4th May 20225:00 pmRNSResult of AGM
25th Apr 20227:00 amRNSQ1 2022 Update, Outlook & Notice of Results
7th Apr 20227:00 amRNSDirector Dealing
4th Apr 20223:49 pmRNSAnnual Report 2021 and Notice of Q1 Update and AGM
29th Mar 202212:22 pmRNSHolding(s) in Company
18th Mar 20221:20 pmRNSResult of Open Offer And Notice of Results
8th Mar 20225:14 pmRNSHolding(s) in Company
8th Mar 20221:52 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSAcquisition of VGL completed and FT1000 inclusion
7th Mar 20227:00 amRNSShare Awards and Exercise of Options
2nd Mar 20223:58 pmRNSDirectors' Dealings
2nd Mar 20223:54 pmRNSHolding(s) in Company
2nd Mar 202211:13 amRNSHolding(s) in Company
28th Feb 202210:07 amRNSResult of Placing and Launch of Open Offer
28th Feb 20227:01 amRNSProposed Acquisition, Placing and Open Offer
28th Feb 20227:00 amRNSUnaudited Preliminary Results Full Year 2021
14th Feb 20227:00 amRNSTrading Update, Acquisitions, Presentations
3rd Feb 20227:00 amRNSInvestor Presentation
17th Jan 20227:00 amRNSTrading Update and Notice of Results
6th Dec 20217:00 amRNSAcquisition Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.